Edition:
United States

Arkema SA (ARKAY.PK)

ARKAY.PK on OTC Markets Group

100.20USD
3:59pm EDT
Change (% chg)

$0.72 (+0.73%)
Prev Close
$99.48
Open
$99.08
Day's High
$100.34
Day's Low
$99.08
Volume
2,574
Avg. Vol
3,476
52-wk High
$102.63
52-wk Low
$70.17

Latest Key Developments (Source: Significant Developments)

Arkema completes divestment of its OXO alcohols business
Thursday, 2 Mar 2017 11:35am EST 

Arkema SA : Announces the completion of the divestment of its Oxo alcohols business . Completed sale to Ineos of its 50 percent stake in Oxochimie .Impact of this divestment on Group's annual sales will represent some 40 million euros ($42.1 million).  Full Article

Arkema FY EBITDA rises to 1.19 billion euros
Tuesday, 28 Feb 2017 01:00am EST 

Arkema SA : FY revenue ​7.54 billion euros versus 7.68 billion euros ($8.14 billion) year ago . FY EBITDA 1.19‍​ billion euros versus 1.06 billion euros year ago . FY net income group share ‍​427 million euros versus 285 million euros year ago . Proposed dividend increase of 8 pct at 2.05 euros per share . In 2017 macroeconomic environment should remain characterized by moderate global growth, mixed dynamics by region and volatility in energy prices, raw materials and currencies . Market conditions in acrylic monomers should gradually improve while PMMA should start to normalize in H2 of 2017 .The group confirms its ambition announced in 2014 to achieve 1.3 billion euros EBITDA in 2017.  Full Article

Arkema announces the proposed divestment of its Oxo-alcohols business
Thursday, 26 Jan 2017 11:35am EST 

Arkema SA : Announces the proposed divestment of its Oxo-alcohols business . As part of program to divest 700 million euros ($746.76 million) sales, group announces project to divest to ineos its stake in Oxochimie .Project to divest stake in Oxochimie to be finalized early 2017.  Full Article

Arkema completes acquisition of Den Braven
Thursday, 1 Dec 2016 11:40am EST 

Arkema SA :Integration of Den Braven offers significant synergies assessed in total at 30 million euros ($31.87 million) at least, and should be accretive to earnings per share and cash as from 2017.  Full Article

Arkema increases specialty polyamides capacities
Tuesday, 6 Sep 2016 02:45am EDT 

Arkema SA : Increases its specialty polyamides global capacities . Is increasing its compounding capacities and in 2017 will bring on stream two production lines to manufacture polyamide 11 in addition to polyamide 10 already produced on site .In the United states, a new investment in Birdsboro site (Pennsylvania) will enable manufacture of new pebax biosourced grades for sports and electronics market.  Full Article

Arkema says Bostik synergies "a little ahead of the game" - conf call
Wednesday, 3 Aug 2016 05:54am EDT 

Arkema SA : Says with regards to Bostik synergies co is "a little ahead of the game" - conference call Further company coverage: [AKE.PA] (Gdynia Newsroom:) ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;)).  Full Article

Arkema Q2 EBITDA rises to ‍​341 million euros
Wednesday, 3 Aug 2016 01:00am EDT 

Arkema Sa : Q2 revenue 1.95 billion euros ($2.19 billion) versus 2.11 billion euros year ago . Q2 net income group share ‍​147 million euros versus 133 million euros year ago . Q2 EBITDA ‍​341 million euros versus 320 million euros year ago . Will carry out, in the 2nd half of the year, a regulatory maintenance turnaround in Kerteh, Malaysia, in thiochemicals .Reaffirms its confidence in its ability to grow ebitda in 2016, and now targets growth in EBITDA of some 7 pct to 9 pct over the year.  Full Article

Arkema's Bostik acquires sealants company Den Braven
Wednesday, 20 Jul 2016 01:00am EDT 

Arkema SA : Subsidiary Bostik expands in high performance sealants with the planned acquisition of Den Braven . Enterprise value is EUR 485 million ($534.13 million), 11 times 2016 EBITDA estimate . Den Braven EUR 350 million estimated sales for 2016 . 12.5% EBITDA margin (2016 estimate) . Synergies assessed at EUR 30 million per year at least, fully achieved within 5 years . EBITDA margin target upgraded to 15% for Bostik by 2020 with recurring capex ranging from 2.5% to 3% of sales . Den Braven's integration will be a new milestone towards achieving target to double Bostik`'s EBITDA by 2020 compared to 2014 . Acquisition comforts company confidence in Bostik's development potential and supports Arkema's 2017 and 2020 targets .Closing is expected to take place in last quarter of 2016.  Full Article

Arkema expands Bostik manufacturing capacities in Malaysia
Wednesday, 25 May 2016 11:35am EDT 

Arkema Sa :Expands Bostik manufacturing capacities in Malaysia.  Full Article

Arkema entrusts Suez with management and recovery of waste
Wednesday, 18 May 2016 04:46am EDT 

Suez Environnement : Arkema entrusts Suez with management and recovery of waste on 28 sites in France .42 million euro ($47.3 million) partnership renewed for four years.  Full Article

More From Around the Web

EU mergers and takeovers (March 3)

BRUSSELS, March 3 The following are mergers under review by the European Commission and a brief guide to the EU merger process: